These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 24474533)

  • 21. Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics.
    Morita K; Wang F; Jahn K; Hu T; Tanaka T; Sasaki Y; Kuipers J; Loghavi S; Wang SA; Yan Y; Furudate K; Matthews J; Little L; Gumbs C; Zhang J; Song X; Thompson E; Patel KP; Bueso-Ramos CE; DiNardo CD; Ravandi F; Jabbour E; Andreeff M; Cortes J; Bhalla K; Garcia-Manero G; Kantarjian H; Konopleva M; Nakada D; Navin N; Beerenwinkel N; Futreal PA; Takahashi K
    Nat Commun; 2020 Oct; 11(1):5327. PubMed ID: 33087716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomics of acute myeloid leukemia.
    Graubert TA; Mardis ER
    Cancer J; 2011; 17(6):487-91. PubMed ID: 22157292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing.
    Malmberg EB; Ståhlman S; Rehammar A; Samuelsson T; Alm SJ; Kristiansson E; Abrahamsson J; Garelius H; Pettersson L; Ehinger M; Palmqvist L; Fogelstrand L
    Eur J Haematol; 2017 Jan; 98(1):26-37. PubMed ID: 27197529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Leukemia stem cell and clonal evolution].
    Yoshimi A; Kurokawa M
    Nihon Rinsho; 2014 Jun; 72(6):1012-7. PubMed ID: 25016797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of next-generation sequencing in acute myeloid leukemia.
    Llop M; Sargas C; Barragán E
    Curr Opin Oncol; 2022 Nov; 34(6):723-728. PubMed ID: 36102349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
    Au CH; Wa A; Ho DN; Chan TL; Ma ES
    Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of molecular genetics to refine prognosis in acute myeloid leukemia.
    Bhatnagar B; Garzon R
    Curr Hematol Malig Rep; 2014 Jun; 9(2):148-57. PubMed ID: 24659319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequencing the AML genome, transcriptome, and epigenome.
    Mardis ER
    Semin Hematol; 2014 Oct; 51(4):250-8. PubMed ID: 25311738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapy.
    Uy GL; Duncavage EJ; Chang GS; Jacoby MA; Miller CA; Shao J; Heath S; Elliott K; Reineck T; Fulton RS; Fronick CC; O'Laughlin M; Ganel L; Abboud CN; Cashen AF; DiPersio JF; Wilson RK; Link DC; Welch JS; Ley TJ; Graubert TA; Westervelt P; Walter MJ
    Leukemia; 2017 Apr; 31(4):872-881. PubMed ID: 27740633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia.
    Jan M; Snyder TM; Corces-Zimmerman MR; Vyas P; Weissman IL; Quake SR; Majeti R
    Sci Transl Med; 2012 Aug; 4(149):149ra118. PubMed ID: 22932223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are results of targeted gene sequencing ready to be used for clinical decision making for patients with acute myelogenous leukemia?
    Rao AV; Smith BD
    Curr Hematol Malig Rep; 2013 Jun; 8(2):149-55. PubMed ID: 23595294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
    Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
    Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?
    Grove CS; Vassiliou GS
    Dis Model Mech; 2014 Aug; 7(8):941-51. PubMed ID: 25056697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and epigenetic determinants of AML pathogenesis.
    Cai SF; Levine RL
    Semin Hematol; 2019 Apr; 56(2):84-89. PubMed ID: 30926095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia.
    Kirtonia A; Pandya G; Sethi G; Pandey AK; Das BC; Garg M
    J Mol Med (Berl); 2020 Aug; 98(8):1069-1091. PubMed ID: 32620999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene mutation patterns of Chinese acute myeloid leukemia patients by targeted next-generation sequencing and bioinformatic analysis.
    Han X; Li W; He N; Feng P; Pang Y; Ji C; Ma D
    Clin Chim Acta; 2018 Apr; 479():25-37. PubMed ID: 29309772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The genomics of acute myeloid leukemia in children.
    Conneely SE; Rau RE
    Cancer Metastasis Rev; 2020 Mar; 39(1):189-209. PubMed ID: 31925603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomics of Acute Myeloid Leukemia Diagnosis and Pathways.
    Bullinger L; Döhner K; Döhner H
    J Clin Oncol; 2017 Mar; 35(9):934-946. PubMed ID: 28297624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene mutations of acute myeloid leukemia in the genome era.
    Naoe T; Kiyoi H
    Int J Hematol; 2013 Feb; 97(2):165-74. PubMed ID: 23359299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Using next generation sequencing technology to analyze gene mutations in patients with acute myeloid leukemia and the impact on prognosis].
    Zhao CX; Wang JM; Li JM; Zou SH; Chen FY; Liang AB; Hou J; Hu XX; Zhang YX; Gu SY; Zhu JY; Li P; Du J; Yang YN; Qin YW; Wang XR; Wang C
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3145-3151. PubMed ID: 31694105
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.